Navigation Links
Actelion Announces Positive Study with Bosentan (Tracleer) in,CTEPH

e list of worldwide patient associations and professional health organizations and additional sources of information.

###

References 1. Nick H & Kim S. Assessment of Operability in Chronic Thromboembolic Pulmonary Hypertension. Proc AmThorac Soc 2006; 3: 584-588 2. Dartevelle P et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004; 23:637-648. 3. LJ Rubin et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med. 2002; 346: 896-903 4. Tracleer® SPC Actelion Ltd Actelion Ltd. is a biopharmaceutical company with its corporate headquarters in Allschwil/Basel, Switzerland. Actelion's first drug Tracleer®, an orally available dual endothelin receptor antagonist, has been approved as a therapy for pulmonary arterial hypertension. Actelion markets Tracleer® through its own subsidiaries in key markets worldwide, including the United States (based in South San Francisco), the European Union, Japan, Canada, Australia and Switzerland. At the end of September 2006, Tracleer® was commercially available in 35 countries worldwide. Actelion, founded in late 1997, is a leading player in innovative science related to the endothelium - the single layer of cells separating every blood vessel from the blood stream. Actelion's over 1,200 employees focus on the discovery, development and marketing of innovative drugs for significant unmet medical needs. Actelion shares are traded on the SWX Swiss Exchange (ticker symbol: ATLN). For further information please contact: Actelion Ltd, Gewerbestrasse 16, CH-4123 Allschwil Investor Contact Roland Haefeli +41 61 565 64 58 +1 650 624 6936 Media Contact Peter Engel +41 61 565 66 28 +1 650 624 6996 http://www.actelion.com Conference Call Actelion will host an Investor Conference Call and discussion/Q&A on Monday, 5 March 2007, 07.45 CET / 01.45 AM EST / 06.45 GMT Dial: +41 (0)91 610 56 00 (Europe) +1 (1) 866 291 4166 (U.S.
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Actelion Announces Positive Study with Bosentan Tracleer CTEPH
(Date:11/24/2014)... 24, 2014 Juno Therapeutics today announced ... to the company,s JCAR015 chimeric antigen receptor product ... relapsed or refractory B-cell acute lymphoblastic leukemia and ... Kettering Cancer Center, where Phase 1 clinical trials ... action is important news for patients who may ...
(Date:11/24/2014)...  Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company ... announced today that Sergio Traversa , chief executive ... "MAIN Event" Micro-Cap Growth Conference on Wednesday, December 3, ... Sunset Bel Air Hotel, which is located at 11461 ... . The presentation is scheduled for 8:30 ...
(Date:11/24/2014)... , Nov. 24, 2014  GlySens Incorporated announced ... million dollar grant from the National Institute of Diabetes ... the National Institutes of Health (NIH).  The grant is ... second generation ICGM™ long term implantable glucose monitoring system.  ... and enrollment is expected to begin before the end ...
Breaking Medicine Technology:Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 3Relmada Therapeutics To Present At LD MICRO Conference 2GlySens Incorporated Awarded $2 Million Grant from the National Institutes of Health 2
... ,, MINNEAPOLIS , July 8 Protectus Medical Devices, ... today it has received Notice of Allowance from the US Patent and ... self-sheathing Safety Syringe, a major step toward it becoming the ... , , ...
... Profil™ Institute for Clinical Research, Inc., a company specializing in early ... Marcus Hompesch , the company,s President and CEO, will serve as ... Diabetes, the American Diabetes Association,s ( ADA ) largest fund-raising event. ... Dr. Hompesch will help ...
Cached Medicine Technology:US Patent Allowed for Spring Action That Separates Protectus Innovative Safety Syringe From All Others 2US Patent Allowed for Spring Action That Separates Protectus Innovative Safety Syringe From All Others 3Profil Institute Teams Up With American Diabetes Association to 'Step Out' Against Diabetes 2Profil Institute Teams Up With American Diabetes Association to 'Step Out' Against Diabetes 3
(Date:11/26/2014)... November 26, 2014 Medical suction and ... out of 5. This score represents steady growth in ... years to 2014 as a result of swelling demand ... machines, which are largely considered nondiscretionary. IBISWorld market research ... buyers have some degree of flexibility, given the low ...
(Date:11/26/2014)... News Facts , Lexmark’s ... RSNA 2014 in Chicago. The company will demonstrate ... images, photos, videos and documents found throughout the ... learn more about these innovative medical content management ... initiatives – that enable more informed clinical decisions, ...
(Date:11/26/2014)... 2014 (HealthDay News) -- Vultures have developed highly specialized ... when eating dead animals, researchers report. The new ... the faces and in the guts of 50 turkey ... average, the faces of the vultures had more than ... their guts, the study found. The findings suggest ...
(Date:11/26/2014)... HealthDay Reporter TUESDAY, Nov. 25, 2014 ... Food and Drug Administration will have many restaurant chains posting ... to movie theater popcorn and ice cream parlor fare. ... home, often consuming less nutritious food and underestimating the calories ... Monday afternoon news conference. Although listing calorie counts ...
(Date:11/24/2014)... From embedded sensors and biometrics to elite training ... take center stage at the FitnessTech Summit , presented ... 2015 International CES® , January 6, 2015 in Las Vegas ... The bond between fitness and technology is stronger than ever ... more about the human body. , “Fitness technology has become ...
Breaking Medicine News(10 mins):Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 2Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 3Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 2Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 3Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 4
... Fitness announced,that it has successfully emerged from chapter ... months after filing for bankruptcy protection on July ... Partners,Master Fund I, Ltd. and Harbinger Capital Partners ... Harbinger invested approximately $233.6 million in exchange for ...
... A visionary leader, Dr.,Maria Cristina Escobar ... outstanding contributions to the prevention and control ... 27th Pan American Sanitary Conference,proceedings today. The ... is bestowed upon creative leaders whose commitment ...
... With record supplies,of influenza vaccine expected to be ... Johnson today urged Pennsylvanians -- especially,those in high- ... by,getting a flu shot. "The flu is ... children and individuals with certain medical conditions,",explained Dr. ...
... (Nasdaq: LMAT ), a provider of peripheral vascular ... agreement to launch a,direct sales force in Italy in ... in Italy through an,exclusive distribution agreement with Serom Medical ... exclusive rights on,January 25, 2008 in exchange for the ...
... are chronically infected with hepatitis B will die from its ... Stanford University School of Medicine has identified the most cost-effective ... hepatitis B often don,t know it, because they can go ... group most likely to be infected with hepatitis B - ...
... entities in the addiction treatment field announced the launch ... (ACTION) Campaign for the improvement of addiction treatment services. ... addiction treatment for individuals in need and to keep ... during National Recovery Month in September, has a goal ...
Cached Medicine News:Health News:Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds 2Health News:Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds 3Health News:Inter-American Leadership Award Bestowed Upon Chilean Chronic Disease Expert 2Health News:Health Secretary Urges Pennsylvanians to Get a Flu Shot 2Health News:LeMaitre Vascular to Start Italian Sales Force 2Health News:LeMaitre Vascular to Start Italian Sales Force 3Health News:Stanford researchers find way to fight treacherous hepatitis B 2Health News:Stanford researchers find way to fight treacherous hepatitis B 3Health News:Stanford researchers find way to fight treacherous hepatitis B 4Health News:Leaders in addiction treatment announce national 'ACTION' campaign 2
...
...
... an easy way to eliminate paper ECG ... money. This Windows-based tool dramatically streamlines ECG ... and the hospital emergency department. You can ... Review high-resolution waveforms on-screen. Edit patient information, ...
... communications software, including Remote Link and Central ... you the tools and choices to effectively ... Send patient tests via email, LAN or ... Philips Zymed Holter analysis applications are used. ...
Medicine Products: